Ochsner Health physicians Dr. Richard Zweifler and Dr. Joseph Tarsia are co-authors on a post hoc analysis carried out in the ...

Lawyers for AstraZeneca, Bristol-Myers Squibb, and Johnson & Johnson argued at a panel hearing in Philadelphia late last week ...

Targets the reduction in CABG-related bleeding severity due to the blood thinning drug, ticagrelor – a major unmet medical need in heart attack ...

Participants were survivors of acute ischemic strokes likely related to their Afib. In the hospital stroke unit, they were ...

Apixaban is a generic oral tablet that’s prescribed for certain types of blood clots. It’s available as the brand-name drug Eliquis. The cost of apixaban, with and without insurance ...

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

comparing the effectiveness of apixaban versus aspirin in preventing ... They strike in the middle of the night without warning. A painful contraction of the calf muscle wrenches sleepers out of ...

What should you do with a patient whose Apple Watch reported a 2-hour episode of atrial fibrillation yesterday, but is in ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Fresh or canned sardines are a healthy part of most people's diet due to the omega-3s, calcium, and essential nutrients.

The findings of this post hoc analysis suggest that both apixaban and aspirin may be effective in preventing adverse clinical outcomes in patients with a history of cancer and cryptogenic stroke.